Orforglipron (1 & 3 MG) SNAC (240 MG)
Encapsulated Research Reagent (90 Capsules)
⚠️ **RESEARCH USE ONLY:** This product is sold strictly for in vitro laboratory research and development purposes ONLY. It is NOT intended for human or veterinary use. Capsules are utilized solely as a precise delivery vessel for laboratory reagents and are NOT for consumption.
Properties
| Name: | Orforglipron (with SNAC) |
|---|---|
| Format: | Encapsulated Powder (Research Reagent) |
| Unit Contents: | 1 mg & 3 mg Orforglipron / 240 mg SNAC (per capsule) |
| Quantity: | 90 Capsules |
| Purity: | ~99% (HPLC) |
| CAS Number: | 2212020-52-3 |
| PubChem CID: | 135565576 |
| Molecular Weight: | 883.0 g/mol |
| Molecular Formula: | C45H43F4N7O7 |
Product Details
Description:
Orforglipron is a synthetic, non-peptide agonist of the glucagon-like peptide-1 (GLP-1) receptor. Unlike traditional peptide-based GLP-1 receptor agonists, it is a small molecule designed to bind to and activate the receptor, mimicking the actions of the endogenous incretin hormone GLP-1.
In a research context, this compound is utilized to study GLP-1 receptor activation, incretin signaling pathways, and related metabolic cellular responses in in vitro models. This product is formulated with SNAC (salcaprozate sodium) as a co-administered research excipient to investigate permeation enhancement and the kinetics of active compound exposure during cellular assays.
Intended Use
- This product is sold strictly for in vitro laboratory research and development purposes ONLY.
- It is NOT intended for human or veterinary use, consumption, diagnostics, therapeutic applications, or any other use outside of controlled laboratory research.
- The encapsulated format is designed for precise reagent handling in a laboratory setting and does not imply suitability for oral administration.
- This product is NOT an FDA-approved drug, dietary supplement, or cosmetic or intended for any clinical use.
Handling and Storage
- Storage: Store at room temperature (20-25°C) in a dry place. Protect from light and moisture.
- Handling: Open capsules carefully to empty contents for solution preparation. Use appropriate sterile laboratory solvents as required by the specific research protocol.
- Safety: Handle using appropriate personal protective equipment (PPE) such as gloves, lab coat, and eye protection, within a controlled laboratory environment.
Quality Assurance
- Our Orforglipron is synthesized to high purity specifications, verified by analytical methods such as HPLC and Mass Spectrometry.
- Purity and content is verified for every batch through third party testing.
Further Information and Verification
For chemical properties and identifiers for Orforglipron, you can search its CAS number (2212020-52-3) on the PubChem website. A direct link to the compound summary is: https://pubchem.ncbi.nlm.nih.gov/compound/135565576.
Disclaimer
Purchase of this product signifies an agreement that it will be used solely for legitimate laboratory research purposes by qualified individuals trained in laboratory procedures and safety. The buyer assumes all responsibility for the proper handling, storage, use, and disposal of this product. The seller makes no claims regarding the suitability of this product for any particular research application beyond its specified chemical identity and purity. This product has not been evaluated by the Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease or condition. All product descriptions and details found on this website are intended for educational, research and informational purposes only.





















